ArticleFrontiers in neuroscience2021

Lipoprotein-Associated Phospholipase A2 Is a Risk Factor for Patients With Parkinson's Disease.

Zubo Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.